Neue Fund

Investor type Venture Capital
Founders Maximilian Winter


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 53
Average round size
The average size of a deal this fund participated in
Portfolio companies 41
Rounds per year 10.60
Lead investments 0
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical Device
  • Software
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Neue Fund:
Typical Co-investors
Neue Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Neue Fund:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Avrhm Capital -
Bowei Zhihong Touzi Beijing, Beijing, China
Chuangchuang Yihao Fund China, Guangdong, Shenzhen
Dexcel Pharma Israel, Jerusalem, Jerusalem District
Efficient Capacity fund California, San Francisco, United States
Fengqiao Capital -
GCI Venture Partners District of Columbia, United States, Washington
IDG Ventures Vietnam Hanoi, Vietnam
Impact America Fund California, Oakland, United States
inpro Berlin, Berlin, Germany
Mana Impact China, Hong Kong, Hong Kong Island
Metier Private Equity Gauteng, NA - South Africa, South Africa
New Era Science-tech Beijing, Beijing, China
Pioneering Ventures Switzerland, Zürich, Zurich
ServiceNow founding members -
Shenzhen Jinqirong Touzi China, Guangdong, Shenzhen Beijing, Beijing, China
Upstart Labs Oregon, Portland, United States
Zhixing Heyi Capital Management China, Japan, Kagoshima Prefecture

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Scribe Biosciences

12 May 2021 San Francisco, California, United States

3D Technology
Augmented Reality
Health Care
Medical Device
$5M13 Apr 2021 City of Saint Louis, Missouri, United States


Health Care
Medical Device
22 Mar 2021 Austin, Texas, United States

VisiCELL Medical

18 Mar 2021 San Diego, California, United States

Artificial Intelligence
Machine Learning
03 Mar 2021 California, United States

Artificial Intelligence
Clinical Trials
Machine Learning
21 Dec 2020 San Diego, California, United States


Industrial Automation
Information Technology
Software Engineering
$1M11 Dec 2020 California, United States

Pathology Watch

Health Care
Medical Device
23 Nov 2020 Utah, United States

Qu Biologics Inc.

Health Care
02 Nov 2020 Vancouver, British Columbia, Canada


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Neue Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: